DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

NCT02711683 · clinicaltrials.gov ↗

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: DL-3-n-butylphthalide
DRUG: Donepezil

Sponsor

First Affiliated Hospital Xi'an Jiaotong University